Expert in launching new medical/health care technologies. I am passionate in the ability to bring new medical technologies to improve patient quality of life, facilitate a more rewarding provider experience and provide returns to investors backing groundbreaking work.I offer a comprehensive set of applicable skills in strategic planning, product management, marketing, branding and operations. In addition to my “roll up your sleeves” independent contributor mindset, my formal MBA education, strategic consulting and healthcare software background enhance my capability to make decisions and manage projects professionally, effectively and efficiently.Specialties: commercialization, product management, marketing, strategic planning, forecasting, personalized medicine, ehealth, digital marketing, molecular diagnostics, medical technology
Jonathan Romanowsky is an expert in launching new medical/health care technologies with over 30 years of experience. He is passionate about improving patient quality of life and facilitating a more rewarding provider experience. With a comprehensive set of skills in strategic planning, product management, marketing, branding, and operations, Jonathan is adept at making informed decisions and managing projects professionally. He has held various leadership positions in companies such as Piction Health, Inflammatix, Telomere Diagnostics, Veracyte, and GE Healthcare. Jonathan's expertise lies in commercialization, product management, marketing, and digital marketing.
Helping every person with a skin issue access personalized, high-quality, expert care quickly and affordably
Redwood City,California,United States
Telomere Diagnostics is a high throughput, CLIA-certified clinical diagnostics laboratory, currently focused on COVID-19 testing. Our national scale and comprehensive clinical and digital solutions enable us to provide a seamless collection, testing and reporting solution. Our current offering consists of saliva and nasal PCR testing for COVID-19.
South San Francisco,California,United States
Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. In addition to making our tests available in the U.S. Through our central laboratories, our exclusive license to a best-in-class diagnostics instrument (the nCounter Analysis System) positions us to deliver our tests to patients worldwide through laboratories that can perform them locally
Redwood City,California,United States
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. Is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. Http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
Bain & Company is a global consultancy that helps the world’s most ambitious change makers define the future. Across 65 cities in 40 countries, we work alongside our clients as one team with a shared ambition to achieve extraordinary results, outperform the competition, and redefine industries. We complement our tailored, integrated expertise with a vibrant ecosystem of digital innovators to deliver better, faster, and more enduring outcomes. Our 10-year commitment to invest more than $1 billion in pro bono services brings our talent, expertise, and insight to organizations tackling today’s urgent challenges in education, racial equity, social justice, economic development, and the environment. We earned a platinum rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings for global supply chains, putting us in the top 1% of all companies. Since our founding in 1973, we have measured our success by the success of our clients, and we proudly maintain the highest level of client
Cross Functional Team Leadership
New Business Development
Product Lifecycle Management
Healthcare Information Technology
Product Life Cycle Management
We found 7 Jonathan Romanowsky's email addresses
We found 7 Jonathan Romanowsky's phone numbers
Jonathan Romanowsky's social media include: Linkedin,
Jonathan Romanowsky works for Inflammatix, Inc.
Jonathan Romanowsky's role in Inflammatix, Inc. is co-founder and chief business officer at inflammatix inc
Jonathan Romanowsky's latest job experience is co-founder and chief business officer at inflammatix inc at Inflammatix, Inc.
Jonathan Romanowsky's latest education in Stanford University Graduate School of Business